About Lophius Biosciences
Lophius Biosciences is a company based in Regensburg (Germany) founded in 2008. Lophius Biosciences has raised $23.73 million across 9 funding rounds from investors including European Union, VRD and Bayern Kapital. The company has 28 employees as of December 31, 2019. Lophius Biosciences operates in a competitive market with competitors including HYCOR BioMedical, Exagen, PredictImmune, Kypha and Immudex, among others.
- Headquarter Regensburg, Germany
- Employees 28 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lophius Biosciences Gmbh
-
Annual Revenue
Not available
-
Net Profit
-$2.75 M (USD)-20as on Dec 31, 2019
-
EBITDA
Not available
-
Total Equity Funding
$23.73 M (USD)
in 9 rounds
-
Latest Funding Round
$3.43 M (USD), Series B
Sep 19, 2019
-
Investors
European Union
& 6 more
-
Employee Count
28
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lophius Biosciences
Lophius Biosciences has successfully raised a total of $23.73M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $3.43 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lophius Biosciences
Lophius Biosciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, VRD and Bayern Kapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment partnerships are provided by a family office for wealth growth.
|
Locked | Locked | Locked | |
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Lophius Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lophius Biosciences
Investment portfolio details for Lophius Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lophius Biosciences
Detailed financials for Lophius Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lophius Biosciences Comparisons
Peer comparison for Lophius Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lophius Biosciences
Lophius Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, PredictImmune, Kypha and Immudex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| Locked | Locked | Locked |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| Locked | Locked | Locked |
Tools for diagnosing immune-mediated inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of immune monitoring reagents and services for research and clinical use
|
Detailed competitors of Lophius Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lophius Biosciences
Complete news archive for Lophius Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lophius Biosciences
Lophius Biosciences was founded in 2008.
Lophius Biosciences is headquartered in Regensburg, Germany. It is registered at Regensburg, Bavaria, Germany.
Lophius Biosciences is a funded company, having raised a total of $23.73M across 9 funding rounds to date.
As of Dec 31, 2019, the latest employee count at Lophius Biosciences is 28.
Develops T-cell-based diagnostics for infectious and immune diseases. It has two proprietary platforms, T-activation Technology which allows the detection of clinically relevant effector cells such as T helper, NK, NKT-like, and CTL cells,and Reverse T cell Technology (RTT) which detects pathogen-specific activated T-cells. The company has two diagnostic kits on the market based on their proprietary platform. T-TRACK CMV for the HLA-independent detection of CMV-specific cell-mediated immunity, and T-TRACK IMMUNOSCAN to check immune response due to natural, induced immunomodulation, In addition, Lophius also provides services and T-cell-based research tools for researchers and biopharma companies.
Lophius Biosciences's top competitors include Exagen, SmartHealth and HYCOR BioMedical.
Lophius Biosciences has 7 investors. Key investors include European Union, VRD, Bayern Kapital, Wohnen in Chemnitz, and BIOTEC KW WOLF.